Prof. Dr. Evrim Metcalfe
Is this your profile? Claim it and verify your details.
Claim profilePerson ↔ Disease
Which topics does this doctor work on?
Medical areas of interest stated by the doctor on the institution profile. Source: medicana.com.tr.
- Baş ve Boyun Kanserleri
- Ürogenital Kanserler
- Akciğer Kanseri
- Geriatrik Onkoloji
- Psikoonkoloji
- Stereotaktik Radyoterapi
- Palyatif ve Destek Bakım
CV
Education and experience
Experience
- 2006-2010Uzman, Samsun Eğitim ve Araştırma Hastanesi Radyasyon Onkolojisi Kliniği (zorunlu hizmet)medicana.com.tr
- 2010-2016Yardımcı Doçent, Radyasyon Onkolojisi Anabilim Dalı, Eskişehirmedicana.com.tr
- 2016-2021Doçent, Eskişehir Osmangazi Üniversitesi Tıp Fakültesi Radyasyon Onkolojisi Anabilim Dalı ve FMV Işık Üniversitesi MYOmedicana.com.tr
- 2021-2023Profesör, Biruni Üniversitesi Tıp Fakültesi Radyasyon Onkolojisi Anabilim Dalımedicana.com.tr
- 2023-2026Profesör, İstanbul Medipol Üniversitesi Radyasyon Onkolojisi Anabilim Dalımedicana.com.tr
- 2026-HalenProfesör, Medicana International İstanbul Hastanesimedicana.com.tr
Education
- 1992-1998Ege Üniversitesi Tıp Fakültesimedicana.com.tr
- 2000-2006Dokuz Eylül Üniversitesi Tıp Fakültesi, Radyasyon Onkolojisimedicana.com.tr
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyRadiation Oncologymedicana.com.trFrom source
- InstitutionMedicana International Istanbul - Beylikdüzümedicana.com.trFrom source
- Publications21 publicationsmedicana.com.tr profile pageFrom source
- Last synchronised7 November 2026 03:25https://www.medicana.com.tr/hekim-detay/25698/evrim-metcalfemedicana.com.tr
Scientific work
Publications
-
Gorken IB, Bayman E, Balci P, et al. Comparing Ultrasound with Computerized Tomography Images to Choose Electron Energy for Radiotherapy Boost Field in Breast Cancer Patients with Breast Conserving Surgery. J BUON. 2010;15(3):500-503.
Source: medicana.com.tr profile page
-
Etiz D, Bayman E, Akcay M, et al. Dosimetric and Clinical Predictors of Acute Esophagitis in Lung Cancer Patients in Turkey Treated with Radiotherapy. Asian Pac J Cancer Prev. 2013;14(7):4223-4228.
Source: medicana.com.tr profile page
-
Etiz D, Ataizi FC, Bayman E, et al. Prognostic Value of Osteopontin in Patients Treated with Primary Radiotherapy for Head and Neck Cancer. Asian Pac J Cancer Prev. 2013;14(9):5175-5178.
Source: medicana.com.tr profile page
-
Erpolat OP, Alco G, Caglar HB, et al. Comparison of Hematologic Toxicity Between 3DCRT and IMRT Planning in Cervical Cancer Patients After Concurrent Chemoradiotherapy: A National Multi-Center Study. Eur J Gynaecol Oncol. 2014;35(1):62-66.
Source: medicana.com.tr profile page
-
Bayman E, Prestwich RJ, Speight R, et al. Patterns of Failure After Intensity-Modulated Radiotherapy in Head and Neck Squamous Cell Carcinoma Using Compartmental Clinical Target Volume Delineation. Clin Oncol (R Coll Radiol). 2014;26(10):636-642.
Source: medicana.com.tr profile page
-
Bayman E, Etiz D, Akcay M, Ak G. Timing of Thoracic Radiotherapy in Limited Stage Small Cell Lung Cancer: Results of Early Versus Late Irradiation from a Single Institution in Turkey. Asian Pac J Cancer Prev. 2014;15(15):6264-6267.
Source: medicana.com.tr profile page
-
Murray L, Sethugavalar B, Robertshaw H, Bayman E, et al. Involved Node, Site, Field and Residual Volume Radiotherapy for Lymphoma: A Comparison of Organ at Risk Dosimetry and Second Malignancy Risks. Clin Oncol (R Coll Radiol). 2015;27(7):401-410.
Source: medicana.com.tr profile page
-
Bird D, Scarsbrook AF, Sykes J, et al. Multimodality Imaging with CT, MR and FDG-PET for Radiotherapy Target Volume Delineation in Oropharyngeal Squamous Cell Carcinoma. BMC Cancer. 2015;15:844.
Source: medicana.com.tr profile page
-
Metcalfe E, Etiz D. Early Transient Radiation-Induced Brachial Plexopathy in Locally Advanced Head and Neck Cancer. Contemp Oncol (Pozn). 2016;20(1):67-72.
Source: medicana.com.tr profile page
-
Metcalfe E, Karaoglanoglu O, Akyazici E. Radiotherapy with or without Temozolomide in Elderly Patients Aged ≥70 Years with Glioblastoma. Contemp Oncol (Pozn). 2016;20(3):251-255.
Source: medicana.com.tr profile page